Products & Pipeline - research on acute care drug candidates for Gram-positive infections, MRSA, multi-drug resistant Gram-negative infections, CDAD, Clostridium-difficile infections, Hepatitis C Virus (HCV) and cardiac surgery

^**	Rights under a license from Astellas Pharma Inc. acquired with Cubist's acquisition of Calixa Therapeutics Inc.